Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem

Detalles Bibliográficos
Autores principales: Sookaromdee, Pathum, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547390/
https://www.ncbi.nlm.nih.gov/pubmed/34760686
http://dx.doi.org/10.4103/ijem.ijem_308_21
_version_ 1784590370608250880
author Sookaromdee, Pathum
Wiwanitkit, Viroj
author_facet Sookaromdee, Pathum
Wiwanitkit, Viroj
author_sort Sookaromdee, Pathum
collection PubMed
description
format Online
Article
Text
id pubmed-8547390
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-85473902021-11-09 Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem Sookaromdee, Pathum Wiwanitkit, Viroj Indian J Endocrinol Metab Letters to the Editor Wolters Kluwer - Medknow 2021 2021-10-26 /pmc/articles/PMC8547390/ /pubmed/34760686 http://dx.doi.org/10.4103/ijem.ijem_308_21 Text en Copyright: © 2021 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Letters to the Editor
Sookaromdee, Pathum
Wiwanitkit, Viroj
Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem
title Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem
title_full Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem
title_fullStr Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem
title_full_unstemmed Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem
title_short Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem
title_sort change of safety interval from hyperviscosity problem in covid-19 vaccine recipient with underlying diabetic problem
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547390/
https://www.ncbi.nlm.nih.gov/pubmed/34760686
http://dx.doi.org/10.4103/ijem.ijem_308_21
work_keys_str_mv AT sookaromdeepathum changeofsafetyintervalfromhyperviscosityproblemincovid19vaccinerecipientwithunderlyingdiabeticproblem
AT wiwanitkitviroj changeofsafetyintervalfromhyperviscosityproblemincovid19vaccinerecipientwithunderlyingdiabeticproblem

Ejemplares similares